Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Le20: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment

NCT00398372 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00398372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00398372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Le20: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2000
Completion date
September 30, 2009
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, non-hodgkin, lymphomas: non-hodgkin, lymphomas: non-hodgkin cutaneous lymphoma, lymphomas: non-hodgkin diffuse large b-cell, lymphomas: non-hodgkin follicular / indolent b-cell, lymphomas: non-hodgkin mantle cell, lymphomas: non-hodgkin marginal zone, lymphomas: non-hodgkin peripheral t-cell, lymphomas: non-hodgkin waldenstr macroglobulinemia